Repository

• Home
• Repository
• Publications

Publications

The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine and durvalumab: a large real-life worldwide population Rimini M, Fornaro L, Lo Prinzi F, Rizzato MD, Saborowski A, Antonuzzo L, Rossari F, Satake T, Peeters F, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Nichetti F, Jae Chon H, Braconi C, Qaisar A, Pirrone C, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Corallo S, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Alvim CM, Roque R, Farinea G, Salani F, De Rosa A, Lavacchi D, Camera S, Ikeda M, Dekervel J, Niger M, Balsano R, Tonini G, Kang M, Bekaii-Saab T, Esposito L, Boccaccino A, Himmelsbach V, Landriscina M, Djaballah SA, Zanuso V, Malapelle U, Pepe F, Masi G, Vogel A, Lonardi S, Rimassa L, Casadei-Gardini A. J Natl Cancer Inst. 2025 Jul 3:djaf155. doi: 10.1093/jnci/djaf155 2025  Result from

Targeting EIF4A1 is effective against human intrahepatic cholangiocarcinoma Mi W, Cigliano A, Galleri G, Gigante I, Steinmann SM, Cibali E, Serra M, Pes GM, Schloesser D, Pizzuto E, Siegmund H, Fischer C, Saborowski A, Giannelli G, Evert M, Wilhelmus van der Laan LJ, Verstegen MMA, Calvisi DF JHEP Rep. 2025 Apr 3;7(7):101416. doi: 10.1016/j.jhepr.2025.101416 2025  Result from

From barriers to solutions: an expert-based algorithm for cholangiocarcinoma and other biliary tract cancers testing in the Era of precision oncology Stenzinger A, Normanno N, Lamarca A, Rimassa L, Bibeau F, Taniere P, Vogel A, Hollebecque A. Expert Rev Mol Diagn. 2025 Jun 29:1-14. doi: 10.1080/14737159.2025.2521538 2025  Result from

A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index Persano M, Rimini M, Salani F, Prinzi FL, Nichetti F, Saborowski A, Antonuzzo L, Passeri L, Satake T, Peeters F, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Corallo S, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Qaisar A, Pirrone C, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Couto N, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Alvim CM, Roque R, Farinea G, Fornaro L, De Rosa A, Lanzetta I, Balsano R, Lavacchi D, Camera S, Ikeda M, Dekervel J, Niger M, Tesini G, Tonini G, Kang M, Bekaii-Saab T, Esposito L, Boccaccino A, Ferrara M, Himmelsbach V, Landriscina M, Djaballah SA, Masi G, Vogel A, Lonardi S, Rimassa L, Casadei-Gardini A. Liver Int. 2025 Jul;45(7):e70181. doi: 10.1111/liv.70181. 2025  Result from

Refinement of histologic subtypes and identification of biomarkers linked to unfavorable prognosis in cholangiocarcinoma: The ENSCCA registries' framework for digital twin advancement Carpino G, Overi D, Macias RI, Cardinale V, Izquierdo-Sanchez L, Acedo P, Rengo M, Doukas M, Kendall TJ, Calderaro J, Heij LR, Reichel K, Leone S, Onori P, Franceschini B, Soldani C, Di Tommaso L, Rodrigues PM, Augustin J, Brustia R, Torzilli G, Martin-Izquierdo M, Hernández-Bayo JM, Bueno-Sacristan D, Lanza E, Garcia-Sampedro A, Quaglia A, Ardito F, De Rose AM, Giuliante F, Damato E, Panebianco V, Groot Koerkamp B, Pereira SP, Grazi GL, Alvaro D, Lleo A, Banales JM, Gaudio E Hepatology. 2025 Jun 16. doi: 10.1097/HEP.0000000000001425 2025  Result from   OA Funded by